Beyond Air Inc

NASDAQ:XAIR

0.41

-0.03 (-5.83%)

6:11:11 PM EDT: $0.43 +0.02 (+4.39%)

Market Cap (Intraday)	17.96M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.04 Million
Adjusted EPS	-$0.28

See more estimates

10-Day MA	$0.43
50-Day MA	$0.51
200-Day MA	$1.27

See more pivots

Beyond Air Inc Stock, NASDAQ:XAIR

900 Stewart Avenue, Suite 301, Garden City, New York 11530

United States of America

Phone: +1.516.665.8200

Number of Employees: 107

http://www.beyondair.net

Description

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.